US.ZTS · Zoetis

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.9961090271364212,
        "turnoverUsdM": 389.82298688786,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.6,
    "stopLevels": {
      "symbol": "US.ZTS",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 72.48,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 2,
        "rsi_score": 3,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.5,
      "stop_loss_percent": 6,
      "take_profit_price": 84.0454,
      "target_multiplier": 2.2,
      "technical_strength": 2.05,
      "take_profit_percent": 9
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.5019480129870129,
    "stopLossPercent": 5.9922180542728425,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 70,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 61,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 9
  },
  "market": {
    "ma20": 75.8965,
    "ma50": 77.1322,
    "close": 77.1,
    "prevClose": 77.29,
    "avgVolume20": 5427449,
    "volumeRatio": 0.93,
    "changePercent": -0.25
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 9,
    "details": {
      "ret_5d": 0.00234006760270411,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 9,
      "vcp_bonus": 0,
      "vol_ratio": 0.9136358626023444,
      "ret_points": 4,
      "vol_points": 0,
      "range_ratio": 1.5974176965332985,
      "volat_points": 4,
      "day_range_pct": 0.04306096090949325,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 70,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 4.3,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 86,
        "contribution": 4.3
      },
      {
        "raw": 14,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 70,
        "contribution": 14
      },
      {
        "raw": 6.8,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 45.33,
        "contribution": 6.8
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 70,
        "contribution": 7
      },
      {
        "raw": 20.9,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 69.67,
        "contribution": 20.9
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "incomplete",
  "standard110": {
    "rating": "觀望",
    "result": 61,
    "details": [
      "基本面分析總分: 4.3/5分",
      "資金流分析總分: 14/20分",
      "市場環境分析總分: 6.8/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7/10分",
      "技術信號分析總分: 20.9/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 4.3,
      "資金流": 14,
      "市場環境": 6.8,
      "情緒分析": 6,
      "技術信號": 20.9,
      "風險管理": 7
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "優秀",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.5,
          "epsPoints": 0.4,
          "roePoints": 0.75,
          "debtPoints": 0.3,
          "marginPoints": 0.75,
          "turnoverUsdM": 389.82298688786,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.4,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "良好",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 3.2,
          "obvPoints": 4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.ZTS",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 0,
            "details": {
              "source": "twelvedata+fred",
              "missing": true,
              "vixClose": null
            }
          },
          "trend": {
            "score": 3,
            "details": {
              "qqq": {
                "ma20": 699.88099675,
                "ma50": 714.8264005399999,
                "name": "QQQ",
                "close": 700.070007,
                "points": 1
              },
              "spy": {
                "ma20": 746.0140036500002,
                "ma50": 745.31840316,
                "name": "SPY",
                "close": 757.66998,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.9961090271364212,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 0,
          "marketTrendPoints": 3
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 1,
              "positiveHits": 5,
              "sentimentScoreRaw": 1.2
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141101186,
                "url": "https://finnhub.io/api/news?id=0353f1b1418a844bfe7c229f841c3c644d7577f8f98b311399e411935e738a84",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis heads into Q2 earnings with companion animal products and international growth in focus as U.S. competition and Librela concerns weigh.",
                "category": "company",
                "datetime": 1785772320,
                "headline": "ZTS Set to Report Q2 Earnings: Here's What Investors Should Expect"
              },
              {
                "id": 141101187,
                "url": "https://finnhub.io/api/news?id=90ee6f8fd67a29e9e5a10d47765417656d90368e3c9f1a1d3a74b0b986362ddb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its “Large Cap Strategy”. A copy of the letter is available to download here. The Strategy returned 3.42% net of fees, trailing the Russell 1000 Value Index’s 13.87% gain. Performance benefited from stock selection in consumer staples, materials and consumer discretionary, along with an underweight in utilities. However, stock […]",
                "category": "company",
                "datetime": 1785766810,
                "headline": "Zoetis (ZTS) Growth Weakens Amid Softening Pet Care Demand"
              },
              {
                "id": 141067135,
                "url": "https://finnhub.io/api/news?id=a185bbf09de890d49ba121002d439e688f8280284dd8e3b0204c23008c56ef3d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1785420024,
                "headline": "Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth"
              },
              {
                "id": 141053246,
                "url": "https://finnhub.io/api/news?id=e04864708b2791ce4dce024bbf3c377742a65883e05b0b1e3c8b6ad378edad44",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Platinum Asset Management, an investment management company, released its Q2 2026 investor letter for “Platinum International Brands Fund”. A copy of the letter can be downloaded here. The fund returned over 4% in the quarter but lost 14% over the past year, primarily due to the dominance of tech stocks amid an AI investment boom. Consumer-focused […]",
                "category": "company",
                "datetime": 1785329940,
                "headline": "Zoetis (ZTS) Slid on Weak Response to Great Ideas"
              },
              {
                "id": 141038234,
                "url": "https://finnhub.io/api/news?id=f2e001d35a24ad9751a7525d7df183f9ba023783f50bd24a540e954b10e82556",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "In the closing of the recent trading day, Zoetis (ZTS) stood at $76.92, denoting a +2.08% move from the preceding trading day.",
                "category": "company",
                "datetime": 1785190503,
                "headline": "Zoetis (ZTS) Beats Stock Market Upswing: What Investors Need to Know"
              },
              {
                "id": 141031147,
                "url": "https://finnhub.io/api/news?id=25c2ecadd89a275d475a65b0d7e5c7c10944a00bc0dd40f351d3def6d7952fb3",
                "image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
                "source": "ChartMill",
                "related": "ZTS",
                "summary": "The Best Dividend Stocks screen identifies companies with strong dividends, profitability, and health. Zoetis (ZTS) stands out with a 1.64% yield, 20.56% dividend growth, and low payout ratio.",
                "category": "company",
                "datetime": 1785139259,
                "headline": "Zoetis (NYSE:ZTS): Dividend Quality Backed by Strong Fundamentals"
              },
              {
                "id": 140994978,
                "url": "https://finnhub.io/api/news?id=cba84e56c1bfe635cf8fcbb16a506eda17b18225a295ad4fa12cc12534a44a1f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Moon Capital Management, LLC, an investment management company, released its second quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 index rebounded in the second quarter, achieving a 9.6% return for the first half of the year, while Moon Capital Management’s equity portfolio gained 4%. AI-related stocks led […]",
                "category": "company",
                "datetime": 1784817264,
                "headline": "Temporary Concerns Present Entry Point in Zoetis (ZTS)"
              },
              {
                "id": 140983329,
                "url": "https://finnhub.io/api/news?id=bdde0e0d4bcdebdddc8cd6326e5e83a1c9a72efb6d35fabb7a65fddf6ca33ccd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis (NYSE:ZTS) has launched Portela, a long acting monoclonal antibody therapy for osteoarthritis pain in cats. The company has also introduced Lenivia, a long acting monoclonal antibody therapy for osteoarthritis pain in dogs. Both products are now commercially available in Canada and the EU, targeting a growing need for sustained pain management in companion animals. Zoetis, trading at around $75.35 per share, is expanding its presence in companion animal health with these dual product...",
                "category": "company",
                "datetime": 1784729611,
                "headline": "Zoetis (ZTS) Launches Two Long Acting Pet Pain Therapies In Canada And Europe"
              }
            ],
            "raw_source": [
              {
                "id": 141101186,
                "url": "https://finnhub.io/api/news?id=0353f1b1418a844bfe7c229f841c3c644d7577f8f98b311399e411935e738a84",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis heads into Q2 earnings with companion animal products and international growth in focus as U.S. competition and Librela concerns weigh.",
                "category": "company",
                "datetime": 1785772320,
                "headline": "ZTS Set to Report Q2 Earnings: Here's What Investors Should Expect"
              },
              {
                "id": 141101187,
                "url": "https://finnhub.io/api/news?id=90ee6f8fd67a29e9e5a10d47765417656d90368e3c9f1a1d3a74b0b986362ddb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its “Large Cap Strategy”. A copy of the letter is available to download here. The Strategy returned 3.42% net of fees, trailing the Russell 1000 Value Index’s 13.87% gain. Performance benefited from stock selection in consumer staples, materials and consumer discretionary, along with an underweight in utilities. However, stock […]",
                "category": "company",
                "datetime": 1785766810,
                "headline": "Zoetis (ZTS) Growth Weakens Amid Softening Pet Care Demand"
              },
              {
                "id": 141093532,
                "url": "https://finnhub.io/api/news?id=029774edf61c80fb92e2cc87f454bb45e5fbaeb0b947089442175e57684b2ede",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2240144272/image_2240144272.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Discover August 2026’s Top 25 high-growth dividend stocks trading below intrinsic value, with yield, growth, and return forecasts—research the list now.",
                "category": "company",
                "datetime": 1785666049,
                "headline": "Top 25 High-Growth Dividend Stocks For August 2026"
              },
              {
                "id": 141090707,
                "url": "https://finnhub.io/api/news?id=10fbbd025a4ab5b6fd0ebf8ee0897edabd47638c367ae16c5cc16405890de91b",
                "image": "",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "",
                "category": "company",
                "datetime": 1785623885,
                "headline": "Top 25 Dividend Stock Opportunities For August 2026"
              },
              {
                "id": 141080295,
                "url": "https://finnhub.io/api/news?id=a1821204767408485cdf2c7c214e1fe8bf7280e81b3f31a2c495ad2dd46c661a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Burry is betting market leadership may soon change",
                "category": "company",
                "datetime": 1785516750,
                "headline": "'Big Short' Investor Takes Fresh Aim at Nvidia"
              },
              {
                "id": 141080289,
                "url": "https://finnhub.io/api/news?id=bfe75e6585ef067cefd4a2ab0aaeaa4fb1b94e36f512b0e40b97736e3c4460c9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Michael Burry Targets Nvidia, Micron With Bigger AI Downside Bets",
                "category": "company",
                "datetime": 1785514872,
                "headline": "Michael Burry Sends Fresh Warning on Nvidia and Micron Stocks"
              },
              {
                "id": 141078471,
                "url": "https://finnhub.io/api/news?id=2e185e671adf043329c8ad262dbe711abae7aa2143e57bd1b616e1a016eba4ea",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/31/Micron-Logo-Displayed-On-A-Smartphone-Sc.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ZTS",
                "summary": "Michael Burry expands short positions against Nvidia and AI, while piling into de-risked value stocks like Lululemon and DraftKings.",
                "category": "company",
                "datetime": 1785489578,
                "headline": "Michael Burry Expands Bets Against Nvidia, Micron— and Is Now Buying Lululemon and DraftKings"
              },
              {
                "id": 141071489,
                "url": "https://finnhub.io/api/news?id=1ee633f74ad4b68b1cb955dffe955dc0147acc8b10839013cd625c39b602e080",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Michael Burry reveals fresh portfolio moves, adding to existing holdings while expanding short positions tied to AI and semiconductor stocks.",
                "category": "company",
                "datetime": 1785447536,
                "headline": "Michael Burry Adds To His NVDA And MU Shorts — And Makes More Moves In These Stocks"
              },
              {
                "id": 141067135,
                "url": "https://finnhub.io/api/news?id=a185bbf09de890d49ba121002d439e688f8280284dd8e3b0204c23008c56ef3d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1785420024,
                "headline": "Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth"
              },
              {
                "id": 141053246,
                "url": "https://finnhub.io/api/news?id=e04864708b2791ce4dce024bbf3c377742a65883e05b0b1e3c8b6ad378edad44",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Platinum Asset Management, an investment management company, released its Q2 2026 investor letter for “Platinum International Brands Fund”. A copy of the letter can be downloaded here. The fund returned over 4% in the quarter but lost 14% over the past year, primarily due to the dominance of tech stocks amid an AI investment boom. Consumer-focused […]",
                "category": "company",
                "datetime": 1785329940,
                "headline": "Zoetis (ZTS) Slid on Weak Response to Great Ideas"
              },
              {
                "id": 141038234,
                "url": "https://finnhub.io/api/news?id=f2e001d35a24ad9751a7525d7df183f9ba023783f50bd24a540e954b10e82556",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "In the closing of the recent trading day, Zoetis (ZTS) stood at $76.92, denoting a +2.08% move from the preceding trading day.",
                "category": "company",
                "datetime": 1785190503,
                "headline": "Zoetis (ZTS) Beats Stock Market Upswing: What Investors Need to Know"
              },
              {
                "id": 141035335,
                "url": "https://finnhub.io/api/news?id=5955aa767bb5270fec33b69b0c4c5c70daa999824702bad4a7ec9365aa0a90a6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Elanco Animal Health (ELAN) seems \"best-positioned name\" into the Q2 print, with IDEXX Laboratories",
                "category": "company",
                "datetime": 1785172169,
                "headline": "Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says"
              },
              {
                "id": 141036204,
                "url": "https://finnhub.io/api/news?id=02bb966645d1b67532c22c4dbd47547c198a9eb1c063d06c28e3f19db648f048",
                "image": "",
                "source": "Benzinga",
                "related": "ZTS",
                "summary": "UBS  analyst Andrea Alfonso   maintains Zoetis (NYSE:ZTS) with a Neutral and lowers the price target from $99 to $85.",
                "category": "company",
                "datetime": 1785160538,
                "headline": "UBS Maintains Neutral on Zoetis, Lowers Price Target to $85"
              },
              {
                "id": 141031147,
                "url": "https://finnhub.io/api/news?id=25c2ecadd89a275d475a65b0d7e5c7c10944a00bc0dd40f351d3def6d7952fb3",
                "image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
                "source": "ChartMill",
                "related": "ZTS",
                "summary": "The Best Dividend Stocks screen identifies companies with strong dividends, profitability, and health. Zoetis (ZTS) stands out with a 1.64% yield, 20.56% dividend growth, and low payout ratio.",
                "category": "company",
                "datetime": 1785139259,
                "headline": "Zoetis (NYSE:ZTS): Dividend Quality Backed by Strong Fundamentals"
              },
              {
                "id": 141005044,
                "url": "https://finnhub.io/api/news?id=83c2461bcf3e54837747f3251ab2778c666c21e7da621a9e9f206f7150e563a8",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2172989407/image_2172989407.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Dividend growers beat the S&P 500 with lower volatility. Click for a look at my investing strategy and my current top income picks.",
                "category": "company",
                "datetime": 1784885400,
                "headline": "Why Dividend Investing Often Wins"
              },
              {
                "id": 141004558,
                "url": "https://finnhub.io/api/news?id=2c0618e3f0c272c251affb0ff2efaa560f4729576b54a80ffcc9d59d8ad50385",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2152961661/image_2152961661.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Zoetis stock trades ~45% below fair value, despite resilient earnings, a low forward P/E, and a 2.8% dividend yield. Learn more. Click for more on ZTS stock.",
                "category": "company",
                "datetime": 1784880000,
                "headline": "Zoetis: Sentiment Keeps Winning As Fundamentals Improve"
              },
              {
                "id": 140994978,
                "url": "https://finnhub.io/api/news?id=cba84e56c1bfe635cf8fcbb16a506eda17b18225a295ad4fa12cc12534a44a1f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Moon Capital Management, LLC, an investment management company, released its second quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 index rebounded in the second quarter, achieving a 9.6% return for the first half of the year, while Moon Capital Management’s equity portfolio gained 4%. AI-related stocks led […]",
                "category": "company",
                "datetime": 1784817264,
                "headline": "Temporary Concerns Present Entry Point in Zoetis (ZTS)"
              },
              {
                "id": 140992567,
                "url": "https://finnhub.io/api/news?id=f03ef675567d5108e942c33fea0af0f892d3babe234791d60ea6de7bc0d32119",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six months, healthcare stocks have gained 10%, nearly mirroring the S&P 500.",
                "category": "company",
                "datetime": 1784802168,
                "headline": "3 Healthcare Stocks with Competitive Advantages"
              },
              {
                "id": 140994068,
                "url": "https://finnhub.io/api/news?id=445d362d38f4196fa82953224ce145c504dab917ac2377007c709936a1102824",
                "image": "",
                "source": "Benzinga",
                "related": "ZTS",
                "summary": "Morgan Stanley  analyst Erin Wright   maintains Zoetis (NYSE:ZTS) with a Overweight and lowers the price target from $115 to $99.",
                "category": "company",
                "datetime": 1784731049,
                "headline": "Morgan Stanley Maintains Overweight on Zoetis, Lowers Price Target to $99"
              },
              {
                "id": 140983329,
                "url": "https://finnhub.io/api/news?id=bdde0e0d4bcdebdddc8cd6326e5e83a1c9a72efb6d35fabb7a65fddf6ca33ccd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis (NYSE:ZTS) has launched Portela, a long acting monoclonal antibody therapy for osteoarthritis pain in cats. The company has also introduced Lenivia, a long acting monoclonal antibody therapy for osteoarthritis pain in dogs. Both products are now commercially available in Canada and the EU, targeting a growing need for sustained pain management in companion animals. Zoetis, trading at around $75.35 per share, is expanding its presence in companion animal health with these dual product...",
                "category": "company",
                "datetime": 1784729611,
                "headline": "Zoetis (ZTS) Launches Two Long Acting Pet Pain Therapies In Canada And Europe"
              },
              {
                "id": 140981128,
                "url": "https://finnhub.io/api/news?id=1a82a22f4ef2013289344a06bde816463202781d35e5e03b98d6e846bb39380e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "PARSIPPANY, N.J., July 22, 2026--Zoetis Inc. (NYSE: ZTS) today announced the commercial launch of Portela® (relfovetmab) in Canada and the European Union (EU) member states. Portela is the first long-acting anti-nerve growth factor (NGF) monoclonal antibody (mAb) therapy for cats, designed to alleviate pain associated with osteoarthritis (OA) for up to three months with a single subcutaneous injection. Backed by nearly a decade of science and research, Portela demonstrated effectiveness in allev",
                "category": "company",
                "datetime": 1784719800,
                "headline": "Zoetis Launches Portela® (relfovetmab) in Canada and the European Union"
              },
              {
                "id": 140984290,
                "url": "https://finnhub.io/api/news?id=af0a145abf1d18d36b7e3b2dbbca656828a76592ca29f93e449f22303bd709eb",
                "image": "",
                "source": "Benzinga",
                "related": "ZTS",
                "summary": "Zoetis Inc. (NYSE:ZTS) today announced the commercial launch of Portela® (relfovetmab) in Canada and the European Union (EU) member states. Portela is the first long-acting anti-nerve growth factor (NGF) monoclonal",
                "category": "company",
                "datetime": 1784705563,
                "headline": "Zoetis Commercially Rolls Out Portela In Canada, EU To Treat Pain Associated With Osteoarthritis"
              },
              {
                "id": 140977786,
                "url": "https://finnhub.io/api/news?id=e5af7044eec4c22e7d5b66cc30423fcd77632bae897fd11a68e5a903c86fe1bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "In the closing of the recent trading day, Zoetis (ZTS) stood at $75.35, denoting a -1.12% move from the preceding trading day.",
                "category": "company",
                "datetime": 1784672105,
                "headline": "Zoetis (ZTS) Stock Dips While Market Gains: Key Facts"
              },
              {
                "id": 140958915,
                "url": "https://finnhub.io/api/news?id=43af2ffc8327254137086db7eefd267160fc0313aef4ac84e45d235f61c64382",
                "image": "https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp",
                "source": "ChartMill",
                "related": "ZTS",
                "summary": "Zoetis (ZTS) offers a rare value opportunity with a P/E of 11.83, top-tier profitability, steady growth, and strong cash flow—a compelling buy for disciplined value investors.",
                "category": "company",
                "datetime": 1784550032,
                "headline": "Zoetis Inc (NYSE:ZTS): A Top Value Stock with Undervalued Strength"
              },
              {
                "id": 140944614,
                "url": "https://finnhub.io/api/news?id=307e412a7579741a0fddefc62643bfcb67d4a3ac5c44974b5af6ec260e2e65c5",
                "image": "https://image.cnbcfm.com/api/v1/image/108335808-1784189865798-gettyimages-168597290-000023514379_Unapproved.jpeg?v=1784189915&w=1920&h=1080",
                "source": "CNBC",
                "related": "ZTS",
                "summary": "Startups are testing GLP-1 treatments for overweight cats while pet-food giants are leaning into longevity products as owners spend more on animal health.",
                "category": "company",
                "datetime": 1784336402,
                "headline": "Fat cat? Weight-loss drugs may be coming for your overweight pet"
              },
              {
                "id": 140936865,
                "url": "https://finnhub.io/api/news?id=57adbdd96ac4de5ef5709d7931a4522a097f6f2bcd0d4d121cb60d00f56ca3fc",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/17/Zoetis-Photo-by-JHVEPhoto-via-Shuttersto.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ZTS",
                "summary": "The Australian agency is conducting a Phase 2 assessment of Zoetis' $160 million acquisition of Neogen's genomics unit due to competition concerns.",
                "category": "company",
                "datetime": 1784282257,
                "headline": "Zoetis' Acquisition of Neogen Genomics Business Faces Regulatory Scrutiny in Australia"
              },
              {
                "id": 140930386,
                "url": "https://finnhub.io/api/news?id=6f9f4286d0d53b3504a08847e2409a0eeaed214f9de5e19de400854993cd8175",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2222771118/image_2222771118.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "We have long viewed Zoetis as one of the highest-quality businesses in healthcare, and the company has generally been valued accordingly.",
                "category": "company",
                "datetime": 1784269980,
                "headline": "Zoetis: An Attractive Risk-Reward Opportunity"
              },
              {
                "id": 140924624,
                "url": "https://finnhub.io/api/news?id=257f4be2d4f4c1a740384ff259a17f6e8b449d9d4212404a24c6ac82be8762b9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis is set to post its second-quarter results next month, and analysts project a single-digit earnings rise.",
                "category": "company",
                "datetime": 1784204533,
                "headline": "Zoetis Earnings Preview: What to Expect"
              },
              {
                "id": 140923106,
                "url": "https://finnhub.io/api/news?id=1411ab81d836486d2ad176e5215d102a8231a34822a4ae642a0a7deac8120f14",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/insider_trade_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ZTS",
                "summary": "July 15, 2026 records indicate that Representative Byron Donalds filed a sale of Cadence Design Systems (NASDAQ:CDNS), valued between $4,004 and $60,000. According to the July filing, the transaction occurred on June 5,",
                "category": "company",
                "datetime": 1784199622,
                "headline": "Recent Report Shows That Rep. Byron Donalds Sold Up to $60K Worth of Cadence Design Systems Stock"
              },
              {
                "id": 140908574,
                "url": "https://finnhub.io/api/news?id=e79b3b2e0aeb7945492530bb6dec50db0f673db2c17a68cc8ff28b2b3da8b1f4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "PARSIPPANY, N.J., July 15, 2026--Zoetis Inc. (NYSE: ZTS) today announced that it has recently launched Lenivia® (izenivetmab injection) in Canada and the European Union (EU) member states – a new long-acting monoclonal antibody (mAb) therapy designed to deliver up to three months of osteoarthritis (OA) pain management with a single subcutaneous injection. Backed by a decade of science and research, Lenivia demonstrated a sustained reduction in pain in a pivotal nine-month European field study, w",
                "category": "company",
                "datetime": 1784118600,
                "headline": "Zoetis Launches Lenivia® (izenivetmab injection) in Canada and the European Union"
              },
              {
                "id": 141071682,
                "url": "https://finnhub.io/api/news?id=4674cd23023d913e8a03b3e33c46f04bea15eda779e5e87337d29be481822d8a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "VitalRADS’ database of more than 30 million images will help Zoetis create radiology AI models.",
                "category": "company",
                "datetime": 1784034003,
                "headline": "Zoetis to acquire medical imaging company in latest push to build AI"
              },
              {
                "id": 140898422,
                "url": "https://finnhub.io/api/news?id=e5aa0ea2dba367e6ec36ccb4d5c5710580554b2938ec2d967c434072ee0bfcc9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "PARSIPPANY, N.J., July 14, 2026--Zoetis Inc. today announced its agreement to acquire VitalRADS, a veterinary teleradiology services platform. Building on the partnership with VitalRADS that Zoetis announced in August 2025, this acquisition adds around-the-clock access to board-certified veterinary specialists through a cloud-based teleradiology platform. Integrating VitalRADS’ capabilities into Zoetis’ Global Diagnostics portfolio enhances Zoetis’ reference laboratory services, delivering AI-as",
                "category": "company",
                "datetime": 1784034000,
                "headline": "Zoetis Announces Agreement to Acquire VitalRADS, Accelerating Diagnostic Capabilities"
              },
              {
                "id": 140903866,
                "url": "https://finnhub.io/api/news?id=280c07f22143b614a04576609dfe0b1077d50f5ded46b06ab84d40f52f51d953",
                "image": "",
                "source": "Benzinga",
                "related": "ZTS",
                "summary": "Zoetis Inc. today announced its agreement to acquire VitalRADS, a veterinary teleradiology services platform. Building on the partnership with VitalRADS that Zoetis announced in August 2025, this acquisition adds",
                "category": "company",
                "datetime": 1784020007,
                "headline": "Zoetis Inks Agreement To Acquire Veterinary Teleradiology Services Platform VitalRADS; Financial Terms Undisclosed"
              },
              {
                "id": 140895489,
                "url": "https://finnhub.io/api/news?id=e9792b8bb3a8cc3da12aa153c4261475841f2de21ef86b38db4538fad88c773a",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2205791995/image_2205791995.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Zoetis has long been viewed as a high-quality compounder.",
                "category": "company",
                "datetime": 1784009990,
                "headline": "Zoetis: Buy When There Is Blood In The Streets"
              },
              {
                "id": 140890874,
                "url": "https://finnhub.io/api/news?id=aeb09051fefdeb721b42719b840455732c5c7611df00d7c438365a90396a98a1",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2232628653/image_2232628653.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "The Undercovered Dozen series spotlights 12 lesser-covered stocks featured on Seeking Alpha between July 3 and July 9. Read the full analysis here.",
                "category": "company",
                "datetime": 1783962834,
                "headline": "Undercovered Dozen: SK Hynix, Reddit, Austal, Netlist, And More"
              },
              {
                "id": 140870870,
                "url": "https://finnhub.io/api/news?id=a9a867d70286d0c18142428aa87a09460037ec679a6825362156d99eff5e61c0",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/688744820/image_688744820.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "July’s top 10 dividend growth stocks with 5-year yield-on-cost ≥2.5% and 5%+ upside; see rankings, fair value gaps & picks like MLI.",
                "category": "company",
                "datetime": 1783760400,
                "headline": "10 Dividend Growth Stocks: July 2026"
              },
              {
                "id": 140866137,
                "url": "https://finnhub.io/api/news?id=3f13457ebf4a4219407fc1e247b73e139d9eff63c7d44cc4326643ba6b21d03b",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the latest list here.",
                "category": "company",
                "datetime": 1783706132,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of July 12"
              },
              {
                "id": 140864246,
                "url": "https://finnhub.io/api/news?id=b1a157383c723c1c371bb7576a64e7316a8e0ae7ac0d7b038f20f7782821f25d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Rescuing a dog or cat can easily turn into a 10- to 20-year financial commitment. Medium-sized dogs often live around 10 to 13 years, while many cats live into their mid-teens and some stretch past 18. The bill that comes with that lifespan is the part many owners never total, because the monthly receipts feel ... A Dividend Portfolio That Pays For Your Pets",
                "category": "company",
                "datetime": 1783701007,
                "headline": "A Dividend Portfolio That Pays For Your Pets"
              },
              {
                "id": 140860770,
                "url": "https://finnhub.io/api/news?id=36712625c3142f03a483933aa600d91604341ab36a2f350e020c937ce2dd724e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.",
                "category": "company",
                "datetime": 1783681880,
                "headline": "2 Value Stocks with Promising Prospects and 1 That Underwhelm"
              },
              {
                "id": 140848304,
                "url": "https://finnhub.io/api/news?id=6632e9600011defeb501e44f3df1b5a70cb7e35c6ce65c5eb8e4e7b6f5430070",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1383864065/image_1383864065.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Fundsmith Equity Fund was down by 2.9% in the first 6 months of the year, 14.1 percentage points less than what is perhaps the most obvious comparator, the MSCI World Index (£ net).",
                "category": "company",
                "datetime": 1783562940,
                "headline": "Fundsmith Equity Fund: H1 2026 Sales"
              },
              {
                "id": 140841979,
                "url": "https://finnhub.io/api/news?id=c15f92bec78bf2b0745b2b7270d085d3b14037479e63b10fbed10593f6532457",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis wins EU approval for a single-dose poultry vaccine against Newcastle and Marek's diseases, expanding its vaccine portfolio and flock protection options.",
                "category": "company",
                "datetime": 1783520100,
                "headline": "ZTS Wins European Commission Approval for New Poultry Disease Vaccine"
              },
              {
                "id": 140839793,
                "url": "https://finnhub.io/api/news?id=303ee684ee433beba364a488812c644cbdf27564c78a5b59a237e3643f317e29",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2172700619/image_2172700619.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Stryker stock looks undervalued with a 13% discount to fair value, a strong EPS growth outlook, and dividend potential. Click for more on SYK stock.",
                "category": "company",
                "datetime": 1783497600,
                "headline": "Stryker: Medtech On Sale, Benefiting From Industry Growth"
              },
              {
                "id": 140839472,
                "url": "https://finnhub.io/api/news?id=dd881bcabc2bb19487918ffbc9709eff68916225493c5faeff1ce53c02d8bc5e",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2220524615/image_2220524615.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "I track a curated universe of 50 high-quality dividend growth stocks to identify opportune entry points based on valuation and future return potential.",
                "category": "company",
                "datetime": 1783496560,
                "headline": "Top 50 High-Quality Dividend Growth Stocks For July 2026"
              },
              {
                "id": 140829259,
                "url": "https://finnhub.io/api/news?id=0887e24718447aa9ef2da64c8a1ce76b8bf996fb0a256545bc255afe6595f4a7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "PARSIPPANY, N.J., July 07, 2026--Zoetis Inc. (NYSE: ZTS) today announced that the European Commission (EC) has granted marketing authorization for Poulvac® Procerta® HVT-ND, a recombinant vector vaccine for the protection of chickens against Newcastle disease (ND) and Marek’s disease viruses. The vaccine can be administered either in ovo or by subcutaneous injection at hatch, providing protection against both diseases with a single dose.",
                "category": "company",
                "datetime": 1783422000,
                "headline": "Zoetis Receives European Commission Marketing Authorization for Poulvac® Procerta® HVT-ND"
              },
              {
                "id": 140836292,
                "url": "https://finnhub.io/api/news?id=d6bb4f374d251708f3f5f27ca97114408f874b016b14d001003f1e0af15e0a6c",
                "image": "",
                "source": "Benzinga",
                "related": "ZTS",
                "summary": "Recombinant vector vaccine protects chickens against Newcastle disease and Marek's disease in a single doseZoetis Inc. (NYSE:ZTS) today announced that the European Commission (EC) has granted marketing authorization",
                "category": "company",
                "datetime": 1783408116,
                "headline": "Zoetis Announces EC Grants Marketing Authorization For Poulvac Procerta HVT-ND, Recombinant Vector Vaccine For Protection Of Chickens Against Newcastle Disease And Marek’s Disease Viruses"
              },
              {
                "id": 140836293,
                "url": "https://finnhub.io/api/news?id=50efe49a20a8f7015575ed5bb9988024cc5d26cba3ec4d07a2ad0297d6de9b3e",
                "image": "",
                "source": "Benzinga",
                "related": "ZTS",
                "summary": "HSBC  analyst Rajesh Kumar   maintains Zoetis (NYSE:ZTS) with a Buy and lowers the price target from $140 to $95.",
                "category": "company",
                "datetime": 1783349423,
                "headline": "HSBC Maintains Buy on Zoetis, Lowers Price Target to $95"
              },
              {
                "id": 140819319,
                "url": "https://finnhub.io/api/news?id=d54f51c9274e88500f47cfe2f2ed1a2d638c4c80328a152b4b149ce5b4dab09f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "(Bloomberg) -- As the deadly New World screwworm spreads through Texas, posing significant risk to the US cattle herd, experts are still puzzling over the mystery of how it got there.Most Read from BloombergGreece Offers Bounty to Catch Ravenous Fish Lured by Warming SeaOil, Gas Tankers Cross Hormuz Via Oman-Side Route After U-TurnsThe Tanker Tycoon Making Millions on Hormuz Shuttle RunsModi’s Flagship Biofuel Push Faces Backlash From MotoristsOil’s Supply Wave, Tumbling Prices Rekindle Fears of",
                "category": "company",
                "datetime": 1783335600,
                "headline": "Deadly Screwworm’s Leap Into the US Mystifies Health Experts"
              },
              {
                "id": 140815344,
                "url": "https://finnhub.io/api/news?id=a37fffb78dfe2e5e4e665ff248af83a603974baa50ebbbc79cb7559fc6007563",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2253627318/image_2253627318.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Zoetis (ZTS) at 12x earnings after a 52% drop: slow growth but dividends strong and 50% upside potential.",
                "category": "company",
                "datetime": 1783274058,
                "headline": "Zoetis: The 60% Decline Was Justified, But Shares Are Finally Buyable"
              },
              {
                "id": 140805197,
                "url": "https://finnhub.io/api/news?id=7ebab30bd35d0b44b0b78d9854944513fc2c795ba351b018ff1fa20b3e0e26ae",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2214049905/image_2214049905.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Explore the 4-Factor dividend growth strategy vs SCHD: returns, recent momentum shifts, and a new ROC/PEG variant test.",
                "category": "company",
                "datetime": 1783134898,
                "headline": "SCHD-Inspired 4-Factor Dividend Growth Strategy Selections For July 2026"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 1,
            "positive_hits": 5,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.2,
            "source_article_count": 49,
            "discarded_article_count": 38
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 20.9,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 1,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1,
            "vcp_reason": "跌縮量(近10日3日)；靠近20日高位；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 6,
              "vol_ref": 6404890,
              "down_days": 3,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 5148040,
              "avg_vol_20": 5534010,
              "avg_vol_30": 6404890,
              "range_pct_10": 0.07626459341801811,
              "range_pct_20": 0.0826200021431909,
              "range_pct_30": 0.1094682259265428,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.8037671216835887,
              "dist_to_20d_high": 0.029334029963489956,
              "down_shrink_days": 3,
              "breakout_level_20d": 79.43,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.6966824644549776
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 4,
          "volumeWeight": 2,
          "maCrossPoints": 0,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.9961090271364212,
              "turnoverUsdM": 389.82298688786,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.6,
          "stopLevels": {
            "symbol": "US.ZTS",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 72.48,
            "strength_details": {
              "ma_score": 1,
              "atr_score": 2,
              "rsi_score": 3,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.5,
            "stop_loss_percent": 6,
            "take_profit_price": 84.0454,
            "target_multiplier": 2.2,
            "technical_strength": 2.05,
            "take_profit_percent": 9
          },
          "positionPoints": 1.6,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.5019480129870129,
          "stopLossPercent": 5.9922180542728425,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [
    {
      "code": "VIX_MISSING",
      "symbol": "US.ZTS",
      "message": "VIX market context is required for market environment scoring",
      "missing": [
        "VIX"
      ],
      "provider": "scoring"
    }
  ],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": false,
    "missingFields": [
      "VIX"
    ],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 100,
    "atr": {
      "atr": 2.31,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 3
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 138.98
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1009
    },
    "kdj": {
      "d": 55.87,
      "j": 58.32,
      "k": 56.69,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 66.31
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": -31316370,
      "recentSlope": 1704913,
      "previousSlope": -2195060
    },
    "rsi": 61.98,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 74.5621,
      "position": "SAR喺價下",
      "distancePct": 3.29,
      "previousTrend": "上升"
    },
    "ma50": 77.1322,
    "macd": {
      "macd": 0.030770742252173022,
      "trend": "強烈看漲",
      "signal": -0.31582418402392043,
      "histogram": 0.34659492627609345
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 76.0055,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 7
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.93,
      "score": 4,
      "avgVolume": 5427449,
      "currentVolume": 5056070
    },
    "derived": {
      "ma20": 75.8965,
      "ma50": 77.1322,
      "prevClose": 77.29,
      "avgVolume10": 5090077,
      "avgVolume20": 5427449,
      "changePercent": -0.25,
      "avgVolumeForScore": 5427449
    },
    "ma_cross": {
      "ma20": 75.8965,
      "ma50": 77.1322,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "熊勢",
      "score": 0,
      "prevMa20": 75.8125,
      "prevMa50": 77.1844,
      "spreadPct": 1.6,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 73.6581,
      "upper": 78.1349,
      "position": "上半部"
    },
    "rsi_short": 64.76,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.93
    }
  }
}

{
  "close": 77.1,
  "volume": 5056070,
  "changePercent": -0.25
}